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Abstract objective To ascertain estimates of adult patients, recorded as lost to follow-up (LTFU) within
antiretroviral treatment (ART) programmes, who have self-transferred care, died or truly stopped
ART in low- and middle-income countries.
methods PubMed, EMBASE, Web of Science, Science Direct, LILACS, IndMed and AIM databases
(2003–2013) and IAS/AIDS conference abstracts (2011–2013) were searched for tracing studies
reporting the proportion of traced patients found to have self-transferred, died or stopped ART.
These estimates were then combined using random-effects meta-analysis. Risk of bias was assessed
through subgroup and sensitivity analyses.
results Twenty eight studies were eligible for inclusion, reporting true outcomes for 10 806 traced
patients attending approximately 258 ART facilities. None were from outside sub-Saharan Africa. Twenty
three studies reported 4.5–54.4% traced LTFU patients self-transferring care, providing a pooled estimate
of 18.6% (95% CI 15.8–22.0%). A significant positive association was found between rates of self-
transfer and LTFU in the ART cohort. The pooled estimates for unreported deaths were 38.8% (95% CI
30.8–46.8%; 27 studies) and 28.6% (95% CI 21.9–36.0%; 20 studies) for patients stopping ART. A
significant decrease in unreported deaths from 50.0% (95% CI
41.5–58.4%) to 30.0% (95% CI 21.1–38.9%) was found comparing study periods before and after 31
December 2007.
conclusions Substantial unaccounted for transfers and deaths amongst patients LTFU confirms
that retention and mortality is underestimated where the true outcomes of LTFU patients are not
ascertained.
keywords Human immunodeficiency virus, antiretroviral therapy, lost to follow-up, mortality,
continuity of care, systematic review
Introduction
Retention in care is a key measure of the success of HIV
treatment programmes. In sub-Saharan Africa, around a
third of patients are reported as lost to follow-up (LTFU)
within 3 years of initiating antiretroviral therapy (ART)
(Fox & Rosen 2010). LTFU is a general term for largely
unknown outcomes of patients who have not returned to
a particular clinic to collect their next supply of ART.
True outcomes for such patients can be divided into three
categories: patients who have self-transferred to another
facility, those who have died and those who have
discontinued treatment (Brinkhof et al. 2009; McMahon
et al. 2013).
With expanding ART coverage, increased decentralisa-
tion of ART services to primary health care and growing
patient confidence to select where to access ART, patients
are increasingly transferring between ART-providing
facilities (Geng et al. 2010b; Nglazi et al. 2013). These
transfers may be formal or undocumented, and the latter
are referred to in this study as ‘self-transfers’. Self-trans-
fers may occur for both health system and personal
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reasons including facility congestion and perceptions of
depersonalised services, permanent or temporary
relocation, lack of patient awareness of transferring pro-
cesses and ease of transferring without documentation
due to increasing numbers of ART providers (Mben et al.
2012; Nglazi et al. 2013; Wubshet et al. 2013). Failure
to account for patients self-transferring care can result in
underestimated retention in ART care. Accurate retention
outcomes are essential to ensure appropriate forecasting,
costing and supply chain management of human resource
requirements, drugs and laboratory investigations, and to
measure the success of ART scale-up (Tweya et al.
2013).
True outcomes of patients classified as LTFU are gener-
ally determined by either active tracing or data linkage to
national death registries (Geng et al. 2010b; Van Cutsem
et al. 2011). While some ART programmes in low- and
middle-income countries conduct tracing routinely, this is
not generally done due to resource constraints. More
commonly, tracing studies have been conducted at a spe-
cific time point on either all or a sample of patents who
are LTFU, to improve classification of unknown out-
comes and link patients back into care (Geng et al.
2010a; Rosen & Ketlhapile 2010; McMahon et al.
2013).
Two previous reviews have highlighted the substantial
numbers of self-transfers amongst LTFU patients. The
first, a systematic review, reported self-transfer rates of
12–54% amongst patients found alive (Brinkhof et al.
2009). The second, a narrative review, estimated a crude
unweighted median self-transfer rate of 48.5% amongst
those reported in 14 cited studies as LTFU (Geng et al.
2010b).
We systematically reviewed outcomes reported in trac-
ing studies of adult ART patients who are reported as
LTFU in low- and middle-income countries (LMICs) to
provide an updated assessment of the extent to which
self-transfers – a positive outcome – contributed to the
overall proportion of people considered to be lost to
care.
Methods
Search strategy
We followed the approach set out in the Preferred
Reporting Items for Systematic reviews and Meta-Analy-
ses guidelines (Moher et al. 2009). Using a predetermined
study protocol (see Web Appendix), we searched seven
databases – PubMed, EMBASE, Science Direct, Web of
Science, Latin American and Caribbean Health Sciences
Literature (LILACS), Indian Medlars Centre (IndMed)
and African Index Medicus (AIM) – from 1 January
2003 to 31 December 2013 to identify observational
cohort studies reporting true outcomes of patients LTFU
in LMICs. Randomised and non-randomised controlled
trials were excluded as these cannot provide representa-
tive estimates of LTFU rates in programme settings.
Highly sensitive search strategies were developed for each
database with the assistance of a professional librarian
(Umscheid 2013), as detailed in the study protocol.
We also searched the conference abstract sites of all
conferences of the International AIDS Society from 2011
to 2013 to enable inclusion of data from studies not pub-
lished to date. All systematic reviews and editorial articles
were identified, and selected studies’ reference lists were
manually searched to identify further studies for eligibil-
ity assessment (Liberati et al. 2009; Moher et al. 2009).
Study selection and data extraction
Studies reporting on HIV patients on ART in LMICs
with LTFU as an outcome were included, provided true
outcomes of all or a subset of LTFU patients were ascer-
tained by tracing. We excluded studies that reported on
infant, paediatric, adolescent or prevention-of-mother-to-
child transmission (PMTCT)-specific cohorts, as well as
studies that reported LTFU amongst patients prior to ini-
tiating ART, unless ART outcomes were also reported
and able to be disaggregated.
Where more than one study reported on the same
cohort, the study reporting on the largest cohort was
included. Where identical cohorts were published, the
study with the latest publication date was included to
obtain the most updated data. Study eligibility assessment
was carried out by one reviewer (LW) and confirmed by
a second reviewer who assessed 10% of titles and 100%
of full articles for eligibility (NF); any discrepancies were
resolved by a third reviewer (JSW). Data were extracted
by one reviewer (LW) and verified by a second reviewer
(OA) using a standardised data extraction form. Informa-
tion was extracted on study and programme characteris-
tics (study period, location and country of study, urban
or rural setting and provider type); cohort characteristics
(number of adult patients initiated on ART; definition of
LTFU; number of reported deaths or formal transfers and
number meeting the LTFU definition) and outcomes
(number of patients in the tracing study, number traced,
tracing methods, reasons for failed tracing and out-
comes). Where discrepancies arose, these were resolved in
consultation with a third reviewer (NF).
To provide consistency across studies, the following
three standardised approaches were taken. Firstly,
patients who could not be traced due to incorrect contact
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details or living outside the tracing area were included in
the tracing study cohort. Secondly, study participants
identified through tracing efforts to have relocated were
considered untraceable (their true outcomes remaining
unknown). Lastly, study participants reported to be
obtaining ART privately were included as self-transfers.
Assessment of heterogeneity and risk of bias in included
studies and across studies
Selected studies were assessed for study-level and out-
come-level risk of bias using the following criteria, which
if not met or uncertain whether met, indicated a risk of
bias: published in peer-reviewed journal; prospective
study design; all or a random sample of LTFU patients
included; more than two-thirds of study participants
traced; disaggregated adult data reported; and method of
tracing included home visits where the patient could not
be reached by telephone. Where the study did not trace
all or a random sample of patients, had limited tracing
success or only traced by telephone, there is a risk that
true outcome results of the study may be affected by
selection bias. Where the study aggregated tracing out-
comes for adults and children, there was an increased risk
that LTFU, tracing success rates and tracing outcomes
may be biased by the paediatric cohort. Risk of bias cate-
gories were not scored for purposes of the meta-analyses
due to the inherent subjectivity in such approaches, but
the potential influence of various study characteristics
was explored through subgroup or sensitivity analysis
(J€uni et al. 1999; Umscheid 2013).
The risk of bias assessment (Web Appendix) was used
as part of the overall assessment of the quality of the evi-
dence.
Statistical analysis and data synthesis
This study’s primary outcome is the percentage of traced
LTFU patients determined to have self-transferred care in
each included study. The secondary outcomes are the per-
centage determined to have died and stopped ART. Point
estimates and 95% confidence intervals (CI) were
calculated for individual studies and combined using ran-
dom-effects meta-analysis on the arcsin scale, then back-
transformed prior to pooling (Freeman 1950; Miller 1978).
Combined estimates were transformed back to percentages.
Heterogeneity between included studies was assessed visu-
ally by forest plot and statistically by estimating the s2 sta-
tistic (Higgins et al. 2003; R€ucker et al. 2008).
The association between the primary outcome and the
proportion LTFU in the ART cohort was explored using
univariate random-effects meta-regression. In addition,
subgroup analyses were undertaken to determine the
potential influence risk of bias covariates, study period
and LTFU period on the primary and secondary out-
comes. Study period stratification was grouped into those
ending before and after 31 December 2007. 2008 was the
year in which the WHO recommended decentralisation
of ART services (WHO 2008), and by which time a num-
ber of high-burden HIV countries had already started
implementing decentralisation, including Malawi,
Mozambique, South Africa and Swaziland (Boulle et al.
2008; Lowrance et al. 2008; Decroo et al. 2011; van
Schalkwyk et al. 2013). LTFU period was stratified into
less or more than 3 months from the patient’s last visit
due to most studies defining LTFU for tracing purposes
as less than 6 months and approximately half defining
such period as less than 3 months. Sensitivity analyses
were carried out to determine the potential influence of
studies that combined outcomes for adults and children
and studies that reported outcomes on an incomplete or
non-random sample of patients.
Analyses were carried out in STATA version 13(Stata-
Corp 2013).
Results
Study selection and characteristics of inclusions
From the initial search, 2597 published items were
retrieved, and another 364 items were identified from
other sources, including 3 from reference lists and 361
from conferences. Of these, 36 met the eligibility criteria,
including 29 full text journal articles and 7 abstracts
from conferences (Figure 1). Eight studies reported on
the same cohort of traced patients. This systematic review
therefore included 28 studies that described true out-
comes of 10 806 LTFU patients attending approximately
258 ART-providing facilities.
A total of 12 countries were represented, all in sub-Sah-
aran Africa, with a third (9/28) from South Africa. Twelve
study cohorts were drawn from urban areas, 6 from rural
and 10 included both urban and rural cohorts. The vast
majority of studies were conducted in public sector facili-
ties with only 2 from the private sector, one of which was
a workplace programme (Dahab et al. 2011). Fifteen stud-
ies were conducted in adult cohorts, five reported data for
adults and children, and the remainder did not specify.
Study characteristics are summarised in Table 1.
Cohort size varied from 352 (Kato et al. 2013) to
47 858 (Toure et al. 2012) patients initiated on ART.
These cohorts were drawn from 1 to 138 healthcare facil-
ities. The percentage of patients classified as LTFU for
tracing purposes ranged from 2.7% (Maskew et al. 2007)
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to 55.4% (Alamo et al. 2012b). Most tracing studies
attempted to trace all LTFU patients, with 3 studies trac-
ing a random sample of patients, two studies tracing a
non-random sample (Krebs et al. 2008; Omotoso 2011)
and 1 study only reporting on the number of patients
traced (Mben et al. 2012).
There was an extensive variability in LTFU definitions
applied for the purposes of determining the study cohort
for tracing. The period for which a patient was missing
before they were considered LTFU ranged from 1 week
to 6 months. This period also varied from either time
since last visit (6 studies) or time since missed appoint-
ment (16 studies). Two studies provided no definition
for LTFU. Reporting of tracing methods was also heter-
ogeneous and not well described in a number of studies;
five studies only attempted to contact patients by tele-
phone, 21 studies attempted to trace by home visit
either after failed telephone contact or not, and two
58 Full text articles 
assessed for eligibility 
2597 Records identified through 
database searching
1365 Records after 
duplicates removed
380 Records after titles 
screened
36 Studies selected
23 Studies included in self-transfer meta-analysis
27 Studies included in the unreported mortality meta-analysis    
20 Studies included in the stopped ART meta-analysis  
1235 Excluded 
duplicates
985 Excluded 
after title screening
322 Excluded 
after abstract 
29 Excluded after 
full text review:
3 Records identified 
through reference 
lists
364 Records identified through 
other sources
361 Records 
identified from 
conferences
7 Records after titles 
and abstracts 
simultaneously 
assessed for eligibility
28 Studies included in the systematic review 
(after removal of 8 studies reporting on same traced cohort) 
Figure 1 Identification and selection of studies flow diagram.
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studies only reported the number of tracing attempts not
the method.
Overall, the quality of evidence contributing to the
assessment of true outcomes of traced LTFU patients was
considered to be low to moderate, mainly due to the risk
of bias within studies, inconsistency in results and impre-
cision in estimates.
True outcomes of LTFU patients traced
A total of 10 806 patients were traced, representing
16.6–96.3% of the overall tracing study cohort. Table 2
summarises the number of patients traced and their true
outcomes. Figures 2–4 summarise the percentage of
traced patients who self-transferred, died and stopped
ART in each study reporting such outcomes, including
confidence intervals (CI) for the point estimates. The
combined self-transfer summary estimate from random-
effects meta-analysis is 18.6% (95% CI 15.8–22.0%).
There was an extensive heterogeneity (s2 0.08,
P < 0.000). The combined summary estimate from ran-
dom-effects meta-analysis for death was 38.8% (95% CI
30.8–46.8%) and patients stopping ART was 28.6%
(95% CI 21.9–36.0%).
Table 2 True outcomes of LTFU patients traced
No. First author
No. in
tracing
study
No.
traced (%)
No. self-
transfers (%)
No. still
at same ART
facility (%)*
No. stopped
care (%) No. alive (%) No. died (%)
1 Alamo 164 158 (96.3) 86 (54.4) 56 (35.4) 142 (89.9) 16 (10.1)
2 Bisson 68 46 (67.7) NR 6 (13.0) 40 (87.0)
3 Caluwaerts 594 214 (36.0) 43 (20.1) 7 (3.3) 46 (21.5) 96 (44.9) 118 (55.1)
4 Chima 343 251 (73.2) NR 120 (47.8) 131 (52.2)
5 Dahab 95 67 (70.5) 3 (4.5) 40 (59.7) 43 (64.2) 24 (35.8)
6 Dalal 267 173 (64.8) 30 (17.3) 60† (34.7) 90 (52.0) 83 (48.0)
7 Deribe 173 108 (62.4) 19 (17.6) 89† (82.4) 108 (100) NR‡
8 Geng 128 111 (86.7) 35§ (31.5) 13§ (11.7) 79 (71.2) 32 (28.8)
9 Gunguwo 161 111 (68.9) 6 (5.4) 16 (14.4) 11 (9.9) 33 (29.7) 78 (70.3)
10 Kato 53 48 (90.6) 10 (20.8) 8 (16.7) 15 (31.3) 33 (68.8) 15 (31.3)
11 Krebs 654 417 (63.8) NR 225 (54.0) 192 (46.0)
12 Maskew 154 70 (45.5) 10 (14.3) 41† (58.6) 51 (72.9) 19 (27.1)
13 Mben NR 231 22 (9.5) 111† (48.1) 133 (57.6) 98 (42.4)
14 McGuire 1186 344 (29.0) 63 (18.3) 48† (14.0) 111 (32.3) 233 (67.7)
15 Miller 40 38 (95.0) 16 (42.1) 2 (5.3) 13¶ (34.2) 31 (81.6) 7 (18.4)
16 Mutevedzi 558 394 (70.6) NR 303 (76.9) 91 (23.1)
17 O’Connor 490 374 (76.3) 71 (19.0) 281 (75.1) 15 (4.0) 367 (98.1) 7 (1.9)
18 Omotoso 185 151 (81.6) 10 (6.6) 27**,¶ (17.9) 132†† (87.4) 19 (12.6)
19 Onoka 219 100 (45.7) 15 (15.0) 4 (4.0) 30¶ (30.0) 49 (49.0) 51 (51.0)
20 Peltzer 169 147 (87.0) 58 (39.5) 7 (4.8) 65 (44.2) 82 (55.8)
21 Rosen 493 260 (52.7) 79 (30.4) 56 (22.0) 70 (26.9) 205 (78.9) 55 (21.2)
22 Saka 1216 202 (16.6) NR NR 114 (56.4) 88 (43.6)
23 Sie 4221 1038 (24.6) 77 (7.4) NR 907 (87.4) 131 (12.6)
24 Toure 11 051 2294 (20.8) 200 (8.7) NR 2104 (91.7) 190 (8.3)
25 Tweya 3510‡‡ 2254 (64.2) 121 (5.4) §§ 1302 (57.8) 952 (42.2)
26 Weigel 1800 534 (29.7) 128 (24.0) 157 (29.4) 32 (6.0) 317 (59.4) 217 (40.6)
27 Wubshet 551 486 (88.2) 118 (24.3) 135 (27.8) 253 (52.1) 233 (47.9)
28 Yu 253 185 (73.1) 20 (10.8) 1 (0.5) 37 (20.0) 58 (31.4) 127 (68.7)
NR, not reported.
*Upon tracing found patients still receiving ART at the same facility. Patient records either incorrect or patients returned to care
between LTFU classification and tracing.
†No. of patients who stopped ART not reported. Ascertained from % breakdown of reasons provided for stopping ART.
‡Author confirmed that deaths determined upon tracing were included in those not traced (not in reported deaths).
§Only directly interviewed 48/79 patients found alive. True outcomes for remaining 31 patients unknown.
¶Patients who upon interviewing refused to answer/denied their HIV status have been added to those reported to have stopped ART.
**Patients reported to have returned to care after tracing not included.
††Reported alive categories add up to 139 (more than those traced less died). Assumed alive = traced less deaths.
‡‡Study reports cases traced not patients. Corresponding author provided data not reported (see Acknowledgements).
§§LTFU cases not patients that stopped ART reported.
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In the random-effects meta-regression (Figure 5), there
was a statistically significant positive association between
the proportion who self-transferred amongst those traced
and the proportion LTFU in the overall ART cohort (b
coefficient 0.5, 95% CI 0–0.9).
Subgroup and sensitivity analysis and investigation of
heterogeneity
Published studies reported a significantly higher percent-
age of self-transfers (21.8%, 95% CI 16.2–27.3%) than
conference abstracts (8.0%, 95% CI 6.3–9.7%)
(P = 0.03). Study period and tracing method significantly
influenced the percentage of unreported deaths. The
percentage of deaths decreased from 50.0% (95% CI
41.5–58.4) to 30.0% (95% CI 21.1–38.9%%) in study
periods ending after 31 December 2007, with a lower
percentage of deaths ascertained where tracing was only
attempted by telephone (21.8%, 95% CI 13.9–29.6% vs.
42.6%, 95% CI 31.8–53.5%).
A tendency towards a lower self-transfer percentage
was found where study periods ended before vs. after
31 December 2007 (16.6%, 95% CI 12.5–20.8% v
20.3%, 95% CI 15.7–25.0%), and where fewer vs.
two-thirds or more study participants were traced
(16.0%, 95% CI 12.3–19.7% v 23.1%, 95% CI
15.0–31.2%).
In sensitivity analysis, exclusion of studies aggregat-
ing outcomes for adults and children, or not specifying
population age, led to a non-statistically significant
increase in percentage of self-transfers (23.8%, 95%CI
15.8–31.8%). Exclusion of non-random tracing cohorts
made no difference. There was also no statistically sig-
nificant difference to the summary estimates of deaths
or stopping ART when performing the same sensitivity
analyses.
Discussion
This review found that almost one in five ART patients
initially reported as LTFU had self-transferred and was
retained in ART care. This finding implies that retention
in ART care in sub-Saharan Africa is underestimated
due to unknown outcomes of LTFU patients. There is
Overall
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Figure 2 Forest plot – percentage traced
LTFU patients found to have self-
transferred.
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evidence that self-transfers have increased after the scale-
up of ART coverage and decentralisation. The significant
positive association found in our study between self-
transfer and LTFU proportions means that programmes
with higher LTFU rates can expect higher self-transfer
rates and a greater underestimation of retention. Two
explanations may provide insight into this finding. Firstly,
LTFU rates have been found to positively correlate with
ART programme size (Boulle et al. 2010) and pro-
gramme expansion rates (Grimsrud et al. 2014), and it is
possible that as cohort sizes expand, patients are more
likely to self-transfer. Secondly, higher LTFU rates have
been found in centralised than primary healthcare facili-
ties (Fatti et al. 2010), indicating that patients may self-
transfer as the number of facilities offering ART increases
and patients are able to access facilities closer to home.
This review also provides an updated summary esti-
mate of 38.8% (95% CI 30.8–46.8%) for mortality
amongst ART patients LTFU, compared with 42% (95%
CI 34–50%) found previously (Brinkhof et al. 2009).
Importantly, we found a significant decrease from 50%
(95% CI 42–58%) to 30% (95% CI 21–39%) in deaths
identified by tracing studies with study periods ending
after 31 December 2007. This may be attributable to
growing access to ART (Grimsrud et al. 2014) and the
reduction in the risk of death associated with patients in
LMICs initiating ART with higher CD4 counts (Gupta
et al. 2011; Avila et al. 2014).
This review differs in several ways from the previous
systematic review of outcomes amongst patients LTFU
published in 2009 (Brinkhof et al. 2009). We excluded
studies reporting pre-ART outcomes; we report the pro-
portion of self-transfers as a percentage of those traced
(not of those found alive upon tracing); and we include
data up to the end of 2013, which allowed for the inclu-
sion of outcomes for more than double the number of
traced patients.
There are inherent limitations to systematic reviews,
especially those summarising results from research con-
ducted in routine care settings. This review has a number
Overall
Geng et al.
Mben et al.
Yu et al.
Bisson et al.
Rosen and Ketlhapile
Onoka et al.
Tweya et al.
Sie et al.
Dahab et al.
McGuire et al.
Omotoso
Wubshet et al.
Dalal et al.
Maskew et al.
Peltzer et al.
O’Connor et al.
Chima and Lupondwana
Study
Miller et al.
Krebs et al.
Kato et al.
Saka et al.
Weigel et al.
Mutevedzi et al
Caluwaerts et al.
Gunguwo et al.
Toure et al.
Alamo et al.
38.84 (30.84, 46.83)
29.02 (21.02, 37.73)
42.46 (36.18, 48.86)
68.55 (61.71, 75.01)
86.19 (74.99, 94.45)
21.26 (16.52, 26.43)
50.99 (41.28, 60.66)
42.24 (40.21, 44.28)
12.66 (10.70, 14.75)
36.03 (25.12, 47.72)
67.68 (62.66, 72.51)
12.83 (8.00, 18.59)
47.95 (43.52, 52.39)
47.99 (40.61, 55.41)
27.46 (17.78, 38.36)
55.74 (47.70, 63.64)
2.00 (0.83, 3.66)
52.18 (46.01, 58.32)
died (95% CI)
19.21 (8.56, 32.88)
46.05 (41.30, 50.84)
31.63 (19.49, 45.19)
43.60 (36.86, 50.46)
40.65 (36.53, 44.84)
23.16 (19.14, 27.45)
55.12 (48.44, 61.70)
70.09 (61.32, 78.18)
8.30 (7.21, 9.46)
10.38 (6.13, 15.57)
Percentage 
Percentage 
0 20 40 60 80 100
Figure 3 Forest plot – percentage traced
LTFU patients found to have died.
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of limitations. Firstly, systematic reviews of routine
programme outcomes are by definition prone to publica-
tion bias, as evidenced by the fact that no studies were
identified that reported outcomes from LMICs outside of
sub-Saharan Africa. It does not appear, however, that
publication bias has favoured the reporting of positive
findings as there was a substantial variability between
studies, including a number of studies reporting relatively
high rates of negative outcomes. Secondly, heterogeneous
definitions of LTFU for tracing purposes may mean that
studies with shorter intervals were likely to have the
number of LTFU patients exaggerated by treatment inter-
rupters (i.e. patients who return to care after a short per-
iod of absenteeism) (Shepherd et al. 2013), thereby
increasing the size of the tracing study cohorts. While
the number of patients who self-transferred or died
should not change, our LTFU definition may have influ-
enced self-transfer and death rates. Thirdly, the lower
self-transfer rate found when limiting the meta-analysis
to studies with poor tracing success suggests that large
numbers of untraceable patients may underestimate the
self-transfer rate (this was not the case for the percentage
deaths). Fourthly, it may not be appropriate to assume
that the true outcomes of untraceable patients are
comparable to those who were traced. Patients with
lower socio-economic status are more likely to stop ART
than self-transfer (Marson et al. 2013), and access to a
telephone (which facilitates tracing) may be an indicator
Overall
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of better socioeconomic status, which in turn may influ-
ence survival. Patients who relocate are also less likely to
be traced. Due to the risk that true outcome results of
tracing studies may be affected by selection bias, correc-
tion of retention and mortality should be investigated
through sensitivity analysis using a range of plausible
self-transfer and mortality estimates. Lastly, tracing
studies used heterogeneous approaches to reporting out-
comes that may influence the comparability of findings
reported.
This review reported tracing a large number of LTFU
patients in both rural and urban ART programmes in 12
sub-Saharan African countries, 11 of which are regarded
as high HIV prevalence countries (WHO 2013). The vast
majority of studies reported on public sector cohorts.
These findings may therefore be representative of high-
prevalence public sector sub-Saharan African cohorts, but
may not be directly generalisable beyond this setting.
These findings confirm the value of tracing patients
LTFU, both to ensure appropriate care is provided for
the individual and to improve the accuracy of outcome
reporting for the overall programme. Due to heteroge-
neous programmes and contexts, retention and mortality
should ideally be reported after tracing all or a random
sample of LTFU patients. Where this is not feasible,
retention and mortality estimates need to be adjusted to
account for self-transferred patients and unreported
deaths. The estimates provided by this study can be used
to inform outcomes amongst patients recorded as LTFU
in sub-Saharan Africa.
In addition, these findings emphasise the importance
of health systems accounting for patient mobility and
transfer as a normal and expected evolution in ART
scale-up. Transfers need to be easily accounted for by
monitoring systems so that self-transfers are not counted
as LTFU. This could be achieved by encouraging the use
of unique patient identifiers that allow tracking of
patients across facilities through standardised integrated
monitoring systems (Harries et al. 2010; Fox et al.
2012). Such systems are unfortunately not perfect, and
mechanisms need to be put in place to ensure patients
are not issued with a new unique identifier at the new
facility (McGuire et al. 2010). Alternative strategies
could include strengthening referral systems and ensuring
a regular exchange of information between facilities (Eg-
ger et al. 2011). As the number of sites providing ART
increases, patient mobility is likely to become more
common and should be supported by increasing patient
awareness and understanding of transfer procedures
(Mben et al. 2012), removing any pre-conditions for
transfer (Wubshet et al. 2013), simplifying facility
processes for transfer (Miller et al. 2010) and providing
incentives in the form of a longer supply of ART.
Longer ART supply also helps cover the period of mov-
ing between facilities thereby limiting unnecessary treat-
ment interruptions (Grimsrud et al. 2013; Tweya et al.
2013). Health authorities should encourage facilities to
be ‘transfer friendly’ so that patients feel comfortable
with communicating their intention to transfer.
This systematic review provides several directions for
future research. ART programmes should continue to
publish tracing studies undertaken as these provide
valuable data to inform future updated systematic
reviews and meta-analysis. In particular, tracing studies
are required from LMICs beyond sub-Saharan Africa
and with study periods after 2010, to further assess
whether self-transfers increase and unreported deaths
decrease with growing ART access and coverage. Future
reviews would be less prone to bias and provide a
better quality of evidence if tracing studies followed a
standardised approach to reporting outcomes. It is par-
ticularly important to report on outcomes of LTFU
patients rather than cases traced and not only on deaths
ascertained but patients who self-transfer, stop ART
and return to care before and after tracing. Tracing
studies should further aim to ascertain the reasons
for a patient self-transferring care. Patients who have
stopped ART should be asked whether they initially
intended transferring their care and which obstacles
prevented such transfer. This would allow assessment of
obstacles to transfer notification and their impact on
continuity of care. Lastly, studies describing appropriate
retention adjustment models are necessary to provide
guidance to those reporting ART cohort outcomes in
the future.
In conclusion, ART programmes with high LTFU rates
can expect large numbers of self-transfers ‘hidden’ in the
LTFU classification. To protect against inappropriate dis-
investment from, and poor forecasting for, ART care pro-
vision, retention estimates need to be adjusted to account
for self-transfers.
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